83 related articles for article (PubMed ID: 9211458)
1. The emergence of acyclovir resistance in mucocutaneous herpes simplex viral infections: implications for clinical practice.
Grodesky MJ
Nurse Pract; 1997 Jun; 22(6):155-6. PubMed ID: 9211458
[No Abstract] [Full Text] [Related]
2. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
Levin MJ; Bacon TH; Leary JJ
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
[TBL] [Abstract][Full Text] [Related]
3. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
4. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
5. [Type 1 herpesvirus cutaneo-mucous infection resistant to aciclovir in a HIV infected patient. Clinical and virological study].
Molina JM; David F; Scieux C; Schnell L; Gerrier F; Kateb M; Morinet F; Modai J
Ann Med Interne (Paris); 1992; 143(3):214-6. PubMed ID: 1388007
[No Abstract] [Full Text] [Related]
6. Viral resistance, clinical experience.
Barry DW; Nusinoff-Lehrman S; Ellis MN; Biron KK; Furman PA
Scand J Infect Dis Suppl; 1985; 47():155-64. PubMed ID: 3006230
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
8. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
Smith NA; Wood C; Asboe D; Bingham JS
AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
[No Abstract] [Full Text] [Related]
9. Foscarnet for herpes.
Posit Aware; 1995; ():5. PubMed ID: 11362667
[TBL] [Abstract][Full Text] [Related]
10. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
11. An unusual vulval lesion in an HIV-infected woman.
Boothby M; Radcliffe K
Int J STD AIDS; 2007 Mar; 18(3):218-9. PubMed ID: 17362560
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
13. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
15. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
16. [Acyclovir (Zovirax). A new antiviral agent against herpes infections].
Kroon S; Petersen CS; Krebs HJ
Ugeskr Laeger; 1984 Sep; 146(38):2888-92. PubMed ID: 6515916
[No Abstract] [Full Text] [Related]
17. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population.
Darville JM; Ley BE; Roome AP; Foot AB
Bone Marrow Transplant; 1998 Sep; 22(6):587-9. PubMed ID: 9758349
[TBL] [Abstract][Full Text] [Related]
20. A retrospective, case-control study of acyclovir resistance in herpes simplex virus.
Malvy D; Treilhaud M; Bouée S; Crochard A; Vallée D; El Hasnaoui A; Aymard M;
Clin Infect Dis; 2005 Aug; 41(3):320-6. PubMed ID: 16007528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
